Boston Scientific Corporation (LON:0HOY)

London flag London · Delayed Price · Currency is GBP · Price in USD
100.64
+2.54 (2.59%)
At close: Nov 25, 2025
11.91%
Market Cap113.98B
Revenue (ttm)14.39B
Net Income (ttm)2.08B
Shares Outn/a
EPS (ttm)1.39
PE Ratio54.90
Forward PE30.31
Dividendn/a
Ex-Dividend Daten/a
Volume1,728
Average Volume5,114
Open98.88
Previous Close98.10
Day's Range98.85 - 100.92
52-Week Range84.86 - 109.51
Beta0.67
RSI53.51
Earnings DateFeb 5, 2026

About Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1979
Employees 53,000
Stock Exchange London Stock Exchange
Ticker Symbol 0HOY
Full Company Profile

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Financial numbers in USD Financial Statements

News

Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion

Boston Scientific, Insulet, BioLife Solutions and Allurion push ahead with innovation and efficiency as the Medical Products industry faces pressure.

8 days ago - Nasdaq

Boston Scientific Up 7% in a Month: How Should You Play the Stock?

BSX's month-long rally, strong Q3 beats and expansion into chronic pain solutions sharpen investor focus.

12 days ago - Nasdaq

Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet

Based on the average brokerage recommendation (ABR), Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness...

14 days ago - Nasdaq

If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

14 days ago - Nasdaq

Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.

15 days ago - Nasdaq

What's Behind Boston Scientific's Optimism for Urology Growth?

BSX sees stronger 2026 prospects for Urology, powered by Axonics integration, innovation and global Stone Management momentum.

16 days ago - Nasdaq

A Look Into Boston Scientific Inc's Price Over Earnings

In the current session, the stock is trading at $99.67, after a 0.62% increase. Over the past month, Boston Scientific Inc. (NYSE: BSX) stock increased by 3.82% , and in the past year, by 11.95% . Wi...

18 days ago - Benzinga

Insider Sell: Ellen Zane Sells Shares of Boston Scientific Corp (BSX)

Insider Sell: Ellen Zane Sells Shares of Boston Scientific Corp (BSX)

19 days ago - GuruFocus

Elutia Inc Reports Q3 2025 Revenue of $3. ...

Elutia Inc Reports Q3 2025 Revenue of $3.3 Million, Missing Estimates; Strategic Sale to Boston Scientific Completed

19 days ago - GuruFocus

Artisan Global Opportunities Fund Q3 2025 Portfolio Update

During the quarter, we initiated new positions in Spotify, L3Harris Technologies and Insmed. We also added to 3i Group, West Pharmaceutical and Amazon during the quarter. We ended our investment campa...

19 days ago - Seeking Alpha

BSX Factor-Based Stock Analysis - Peter Lynch

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investor model based on the published strategy ...

20 days ago - Nasdaq

Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)

Beyond the Balance Sheet: What SWOT Reveals About Boston Scientific Corp (BSX)

22 days ago - GuruFocus

Boston Scientific announces upcoming investor conference schedule

MARLBOROUGH, Mass. , Nov. 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.

23 days ago - PRNewsWire

Demographic Megatrend: Stocks Poised to Benefit From Global Aging

Global aging is reshaping healthcare demand. Discover how AbbVie, Amgen, Boston Scientific and Edwards are positioned to gain from this powerful megatrend.

25 days ago - Nasdaq

BSX December 12th Options Begin Trading

Investors in Boston Scientific Corp. (Symbol: BSX) saw new options begin trading today, for the December 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BS...

26 days ago - Nasdaq

Ellen Zane Sells Shares of Boston Scientific Corp

Ellen Zane Sells Shares of Boston Scientific Corp

4 weeks ago - GuruFocus

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific (NYSE: BSX) has outperformed the market over the past 10 years by 5.86% on an annualized basis producing an average annual return of 18.39%. Currently, Boston Scientific has a marke...

4 weeks ago - Benzinga

Baron Health Care Fund Q3 2025 Top Contributors And Detractors

Argenx SE is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. RadNet, Inc. is the largest operator of outpatient diagno...

4 weeks ago - Seeking Alpha

Boston Scientific: Continuing Its M&A Playbook, As Organic Achievements Impress

Boston Scientific shows strong organic growth, margin expansion, and strategic acquisitions, trading at a premium with long-term potential. See why BSX stock is a hold.

4 weeks ago - Seeking Alpha

Boston Scientific Corporation (BSX) Announces Board Member John E. ...

Boston Scientific Corporation (BSX) Announces Board Member John E. Sununu's Decision Not to Seek Re-election

4 weeks ago - GuruFocus

Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst

On Wednesday, Boston Scientific Corporation (NYSE: BSX) reported third-quarter 2025 revenues of $5.07 billion, beating the consensus estimate of $4.97 billion . The medical technology giant reported ...

4 weeks ago - Benzinga

What the Options Market Tells Us About Boston Scientific

Deep-pocketed investors have adopted a bullish approach towards Boston Scientific (NYSE: BSX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga u...

4 weeks ago - Benzinga